Maddie Meyer/Getty Images News Following an over 12% decline within the earlier session in response to updates on the firm’s R&D Day occasion, Moderna (NASDAQ:MRNA) shares…
Browsing: NASDAQMRNA
hapabapa Moderna (NASDAQ:MRNA) is planning to launch a messenger-RNA-based vaccine for skin cancer as early as subsequent yr, Japanese enterprise publication Nikkei reported on Thursday, citing…
Moderna (NASDAQ:MRNA) shares fell roughly 10% premarket on Thursday after the vaccine maker detailed plans to chop its annual R&D expense by $1.1B beginning in 2027.…